Morningstar - Stellantis N.V. (FCAUN) Fiat Chrysler Faces Key-Person Risk Sooner Than Anticipated; Maintaining EUR 25 FVE

Report

Morningstar

Richard Hilgert

EUR 100.00 For Business Accounts Only

Fiat Chrysler Faces Key-Person Risk Sooner Than Anticipated; Maintaining EUR 25 FVE

No-moat-rated Fiat Chrysler has announced that the board of directors has accelerated the CEO transition plan and named Mike Manley CEO of the company. Manley was one of three executives that were rumored to be in the running to replace Sergio Marchionne in April next year. The announcement stated that Marchionne had undergone surgery but has suffered complications that have worsened significantly, rendering him unable to return to work.
Key-person risk at the loss of Marchionne's leadership is ...

23/07/2018 15 EN

Underlying

Stellantis N.V.

Fiat Chrysler Automobiles is a holding company. Through its subsidiaries, Co. is an international automotive group engaged in designing, engineering, manufacturing, distributing and selling vehicles, components and production systems. Co. has operations in approx. 40 countries and sells its vehicles directly or through distributors and dealers in more than 140 countries. Co. designs, engineers, manufactures, distributes and sells vehicles for the mass market under the Abarth, Alfa Romeo, Chrysler, Dodge, Fiat, Fiat Professional, Jeep, Lancia and Ram brands and the SRT performance vehicle designation.

See profile

NL0010877643 Mexican Stock Exchange United Kingdom

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

Richard Hilgert

Other Reports on these Companies

Pelham Smithers Associates Ltd

PSA Autos, New Mobility: EV Markets in Trouble – Have the Japanese Been Vindicated?

While Japan’s automakers have upped their game in the EV space, they remain laggards on the global stage. With the EV markets now in trouble, analyst Julie Boote assesses whether or not the Japanese assemblers have been vindicated in their more cautious approach to electrification.

January 5, 2024 January 5, 2024 1 EN

Oddo BHF

ODDO : Plastic Omnium gives itself the means to match its ambitions on carbon neutrality

>Carbon neutrality on scopes 1+2 by 2025, -30% on scope 3 by 2030 - Yesterday, Plastic Omnium announced that it has committed to achieving carbon neutrality on scopes 1 and 2 by 2025 and reducing its scope 3 emissions by 30% in 2030. This new target announced in the morning was followed in the afternoon by a presentation of one and half hours on the group’s carbon neutrality strategy. Laurent Favre, CEO, David Meneses, director of sustainable development, and Kathleen...

December 9, 2021 December 9, 2021 1 EN

Oddo BHF

ODDO : Plastic Omnium se donne les moyens de ses ambitions sur la neutralité carbone

>Neutralité carbone scopes 1+2 d’ici 2025, -30% sur le scope 3 d’ici 2030 - Plastic Omnium a annoncé hier s’engager à atteindre la neutralité carbone sur les scopes 1 et 2 d'ici 2025 et à réduire le scope 3 de 30% en 2030. Ce nouvel engagement annoncé le matin a été assorti l’après-midi d’une présentation d’une heure trente de la stratégie de neutralité carbone du groupe. Laurent Favre, DG, David Meneses, Directeur du Développement Durable, et Kathleen Wantz-O’Rourke,...

December 9, 2021 December 9, 2021 1 FR

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Fiat Chrysler Faces Key-Person Risk Sooner Than Anticipated; Maintaining EUR 25 FVE

PSA Autos, New Mobility: EV Markets in Trouble – Have the Japanese Been Vindicated?

ODDO : Plastic Omnium gives itself the means to match its ambitions on carbon neutrality

ODDO : Plastic Omnium se donne les moyens de ses ambitions sur la neutralité carbone

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe